Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Archives of Dermatological Research

26.08.2019 | Review

Promising plant-derived secondary metabolites for treatment of acne vulgaris: a mechanistic review

verfasst von: Samaneh Soleymani, Mohammad Hosein Farzaei, Arman Zargaran, Somayeh Niknam, Roja Rahimi

Erschienen in: Archives of Dermatological Research

Einloggen, um Zugang zu erhalten

Abstract

Acne vulgaris is the most common skin condition associated with inflammation of pilosebaceous unit. Since conventional therapies have not demonstrated desirable effectiveness and possess remarkable side effects, there is a growing interest in the use of herbal medicines for the management of acne vulgaris. In this study, plant-derived molecules investigated in acne vulgaris have been reviewed and their possible underlying mechanisms of action were discussed. For this purpose, different electronic databases including PubMed, Scopus, Cochrane library and Google Scholar were searched to obtain any in vitro, in vivo, or human studies evaluating the phytochemicals in the management of acne vulgaris. Data were collected from 1980 to 2018 (up to October). Most of the phytochemicals investigated in acne were from the category of polyphenols including resveratrol, myricitrin, schisandrin, terchebulin, alpha-mangotin, curcumin, ellagic acid and epigallocatechin 3-gallate. Moreover, alkaloids and terpenoids such as berberine, ursolic acid, lupeol were evaluated in acne vulgaris with less abundance. Various molecular mechanisms were involved in effects of phytochemicals including antioxidant (through down-regulation of H2O2, MDA, ROS and upregulation of SOD), anti-inflammatory (through reduction of proinflammatory cytokines, i.e., IL-1ß, IL-6, IL-8, TGF-β, TNF-α, NF-κB), immunomodulatory, antibacterial (against Propionibacterium acnes and Propionibacterium granulosum), antiandrogenic, reducing sebum production, and lipogenesis inhibitory activities. Therefore, phytochemicals seem to be a precious source for identifying new medicines for treatment of acne vulgaris; however, since most of studies are preclinical, further clinical studies are needed to achieve more conclusive and reliable results.
Literatur
1.
Song YH, Cai H, Gu N et al (2011) Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure. J Pharm Pharmacol 63(4):541–549PubMed
2.
Liu CH, Huang HY (2013) In vitro anti-propionibacterium activity by curcumin containing vesicle system. Chem Pharm Bull (Tokyo) 61(4):419–425
3.
Zouboulis C, Eady A, Philpott M et al (2005) What is the pathogenesis of acne? Exp Dermatol 14(2):143PubMed
4.
Wu T-Q, Mei S-Q, Zhang J-X et al (2007) Prevalence and risk factors of facial acne vulgaris among Chinese adolescents. Int J Adolesc Med Health 19(4):407–412PubMed
5.
Perkins AC, Maglione J, Hillebrand GG, Miyamoto K, Kimball AB (2012) Acne vulgaris in women: prevalence across the life span. J Womens Health 21(2):223–230
6.
Zaenglein AL, Pathy AL, Schlosser BJ et al (2016) Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 74(5):945–73.e33
7.
Bhate K, Williams H (2013) Epidemiology of acne vulgaris. Br J Dermatol 168(3):474–485PubMed
8.
Rapp SR, Feldman SR, Graham G et al (2006) The acne quality of life index (Acne-QOLI). Am J Clin Dermatol 7(3):185–192PubMed
9.
Kapoor S, Saraf S (2011) Topical herbal therapies an alternative and complementary choice to combat acne. Res J Med Plant 5(6):650–659
10.
Tahir I, Khan MR, Shah NA, Aftab M (2016) Evaluation of phytochemicals, antioxidant activity and amelioration of pulmonary fibrosis with Phyllanthus emblica leaves. BMC Complement Altern Med 16(1):406PubMedPubMedCentral
11.
Williams HC, Dellavalle RP, Garner S (2012) Acne vulgaris. Lancet 379(9813):361–372PubMed
12.
Hosein Farzaei M, Bahramsoltani R, Rahimi (2016) Phytochemicals as adjunctive with conventional anticancer therapies. Curr Pharm Des 22(27):4201–4218
13.
Bahramsoltani R, Farzaei MH, Rahimi (2014) Medicinal plants and their natural components as future drugs for the treatment of burn wounds: an integrative review. Arch Dermatol Res 306(7):601–617PubMed
14.
Azimi H, Fallah-Tafti M, Khakshur AA, Abdollahi M (2012) A review of phytotherapy of acne vulgaris: perspective of new pharmacological treatments. Fitoterapia 83(8):1306–1317PubMed
15.
Nishijima S, Kurokawa I, Katoh N, Watanabe K (2000) The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions. J Dermatol 27(5):318–323PubMed
16.
Gollnick H (2003) Current concepts of the pathogenesis of acne. Drugs 63(15):1579–1596PubMed
17.
Ganceviciene R, Fimmel S, Glass E, Zouboulis CC (2006) Psoriasin and follicular hyperkeratinization in acne comedones. Dermatology 213(3):270–272PubMed
18.
Degitz K, Placzek M, Borelli C, Plewig G (2007) Pathophysiology of acne. J Dtsch Dermatol Ges 5(4):316–323PubMed
19.
Vora J, Srivastava A, Modi H (2017) Antibacterial and antioxidant strategies for acne treatment through plant extracts. Inf Med Unlock 13:128–132
20.
Kim J, Ochoa M-T, Krutzik SR et al (2002) Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169(3):1535–1541PubMedPubMedCentral
21.
Jeremy AH, Holland DB, Roberts SG, Thomson KF, Cunliffe WJ (2003) Inflammatory events are involved in acne lesion initiation. J Invest Dermatol 121(1):20–27PubMed
22.
23.
Downie MM, Kealey T (1998) Lipogenesis in the human sebaceous gland: glycogen and glycerophosphate are substrates for the synthesis of sebum lipids. J Invest Dermatol 111(2):199–205PubMed
24.
McNairn AJ, Doucet Y, Demaude J et al (2013) TGFβ signaling regulates lipogenesis in human sebaceous glands cells. BMC Dermatol 13(1):2PubMedPubMedCentral
25.
Lyon CC (2001) Acne: diagnosis and management. SAGE Publications Sage UK, London
26.
Arican O, Kurutas EB, Sasmaz S (2005) Oxidative stress in patients with acne vulgaris. Mediators Inflamm 2005(6):380–384PubMedPubMedCentral
27.
Jung H-A, Su B-N, Keller WJ, Mehta RG, Kinghorn AD (2006) Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen). J Agric Food Chem 54(6):2077–2082PubMed
28.
Asasutjarit R, Larpmahawong P, Fuongfuchat A, Sareedenchai V, Veeranondha S (2014) Physicochemical properties and anti-Propionibacterium acnes activity of film-forming solutions containing alpha-mangostin-rich extract. AAPS Pharm Sci Tech 15(2):306–316
29.
Zou W, Yin P, Shi Y et al (2019) A novel biological role of α-Mangostin via TAK1-NF-κB pathway against inflammatory. Inflammation 42(1):103–112PubMed
30.
Franceschelli S, Pesce M, Ferrone A et al (2016) A novel biological role of alpha-mangostin in modulating inflammatory response through the activation of SIRT-1 signaling pathway. J Cell Physiol 231(11):2439–2451PubMed
31.
Fang Y, Su T, Qiu X et al (2016) Protective effect of alpha-mangostin against oxidative stress induced-retinal cell death. Sci Rep 6:1018–1038
32.
Marquez-Valadez B, Maldonado PD, Galvan-Arzate S et al (2012) Alpha-mangostin induces changes in glutathione levels associated with glutathione peroxidase activity in rat brain synaptosomes. Nutr Neurosci 15(5):13–19PubMed
33.
Kou X, Chen N (2012) Pharmacological potential of ampelopsin in Rattan tea. Food Sci Hum Wellness 1(1):14–18
34.
Qi S, Xin Y, Guo Y et al (2012) Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol 12(1):278–287PubMed
35.
Weng L, Zhang H, Li X et al (2017) Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the inhibition of the NF-κB and JAK2/STAT3 signaling pathways in microglia. Int Immunopharmacol 44:1–8PubMed
36.
Hou X, Zhang J, Ahmad H et al (2014) Evaluation of antioxidant activities of ampelopsin and its protective effect in lipopolysaccharide-induced oxidative stress piglets. PLoS ONE 9(9):e108314PubMedPubMedCentral
37.
Farzaei MH, Rahimi R, Abdollahi M (2015) The role of dietary polyphenols in the management of inflammatory bowel disease. Curr Pharm Biotechnol 16(3):196–210PubMed
38.
Lee KE, Youm JK, Lee WJ, Kang S, Kim YJ (2017) Polyphenol-rich apple extract inhibits dexamethasone-induced sebaceous lipids production by regulating SREBP1 expression. Exp Dermatol 26(10):958–960PubMed
39.
Lu Y, Foo LY (2000) Antioxidant and radical scavenging activities of polyphenols from apple pomace. Food Chem 68(1):81–85
40.
Skyberg JA, Robison A, Golden S et al (2011) Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. J Leukoc Biol 90(6):1043–1054PubMedPubMedCentral
41.
Xu ZR, Li JY, Dong XW et al (2015) Apple polyphenols decrease atherosclerosis and hepatic steatosis in ApoE−/− mice through the ROS/MAPK/NF-kappaB pathway. Nutrients 7(8):7085–7105PubMedPubMedCentral
42.
Etti IC, Abdullah R, Kadir A et al (2017) The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells. PLoS ONE 12(8):e0182357PubMedPubMedCentral
43.
Nayak M, Nagarajan A, Majeed M, Nagabhushanam K, Choudhury AK (2017) In vitro anti-acne activity of phytoactives from the stem bark of Artocarpus hirsutus Lam. and characterisation of pyranocycloartobiloxanthone A as a mixture of two anomers. Nat Prod Res 2017:1–5
44.
Reddy GR, Ueda N, Hada T et al (1991) A prenylflavone, artonin E, as arachidonate 5-lipoxygenase inhibitor. Biochem Pharmacol 41(1):115–118PubMed
45.
Li CG, Yan L, Jing YY et al (2017) Berberine augments ATP-induced inflammasome activation in macrophages by enhancing AMPK signaling. Oncotarget 8(1):95–109PubMed
46.
Spatuzza C, Postiglione L, Covelli B et al (2014) Effects of berberine and red yeast on proinflammatory cytokines IL-6 and TNF-alpha in peripheral blood mononuclear cells (PBMCs) of human subjects. Front pharmacol 5:230PubMedPubMedCentral
47.
Zhang H, Shan Y, Wu Y et al (2017) Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-kappaB signaling pathway in RAW264.7 cells. Int Immunopharmacol 52:93–100
48.
Sun Y, Yuan X, Zhang F et al (2017) Berberine ameliorates fatty acid-induced oxidative stress in human hepatoma cells. Sci Rep 7(1):11340PubMedPubMedCentral
49.
Sadeghnia HR, Kolangikhah M, Asadpour E, Forouzanfar F, Hosseinzadeh H (2017) Berberine protects against glutamate-induced oxidative stress and apoptosis in PC12 and N2a cells. Iran J Basic Med Sci 20(5):594–603PubMedPubMedCentral
50.
Tian Y, Zhao L, Wang Y et al (2016) Berberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells. Asian J Androl 18(4):607–612PubMed
51.
Seki T, Morohashi M (1993) Effect of some alkaloids, flavonoids and triterpenoids, contents of Japanese–Chinese traditional herbal medicines, on the lipogenesis of sebaceous glands. Skin Pharmacol Physiol 6(1):56–60
52.
Farzaei MH, Zobeiri M, Parvizi F et al (2018) Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients 10:7PubMedCentral
53.
Haghi A, Azimi H, Rahimi R (2017) A comprehensive review on pharmacotherapeutics of three phytochemicals, curcumin, quercetin, and Allicin, in the treatment of gastric cancer. J Gastrointest Cancer 48(4):314–320PubMed
54.
Liu CH, Huang HY (2012) Antimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidis. Chem Pharm Bull 60(9):1118–1124PubMed
55.
Dai J, Gu L, Su Y et al (2018) Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-kappaB pathways. Int Immunopharmacol 54:177–187PubMed
56.
Zhang Z, Li K (2018) Curcumin attenuates high glucose-induced inflammatory injury through the reactive oxygen species-phosphoinositide 3-kinase/protein kinase B-nuclear factor-kappaB signaling pathway in rat thoracic aorta endothelial cells. J Diabetes Investig 9(4):731–740PubMed
57.
Yu S, Wang M, Guo X, Qin R (2018) Curcumin attenuates inflammation in a severe acute pancreatitis animal model by regulating TRAF1/ASK1 signaling. Med Sci Monit 24:2280–2286PubMedPubMedCentral
58.
Sivasankar C, Maruthupandiyan S, Balamurugan K et al (2016) A combination of ellagic acid and tetracycline inhibits biofilm formation and the associated virulence of Propionibacterium acnes in vitro and in vivo. Biofouling 32(4):397–410PubMed
59.
Umesalma S, Sudhandiran G (2010) Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-κB, iNOS, COX-2, TNF-α, and IL-6 in 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 107(2):650–655PubMed
60.
Rios JL, Giner RM, Marin M, Recio MC (2018) A pharmacological update of ellagic acid. Planta Med
61.
Rozentsvit A, Vinokur K, Samuel S, Li Y, Gerdes AM, Carrillo-Sepulveda MA (2017) Ellagic acid reduces high glucose-induced vascular oxidative stress through ERK1/2/NOX4 signaling pathway. Cell Physiol Biochem 44(3):1174–1187PubMed
62.
Ural MS, Yonar ME, Mise Yonar S (2015) Protective effect of ellagic acid on oxidative stress and antioxidant status in Cyprinus carpio during malathion exposure. Cell Mol Biol (Noisy-le-grand) 61(5):58–63
63.
Uzar E, Alp H, Cevik MU et al (2012) Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci 33(3):567–574PubMed
64.
Farzaei MH, Shahpiri Z, Bahramsoltani R et al (2017) Efficacy and tolerability of phytomedicines in multiple sclerosis patients: a review. CNS Drugs 31(10):867–889PubMed
65.
Yoon JY, Kwon HH, Min SU, Thiboutot DM, Suh DH (2013) Epigallocatechin-3-gallate improves acne in humans by modulating intracellular molecular targets and inhibiting P. acnes. J Invest Dermatol 133(2):429–440PubMed
66.
Koseki J, Matsumoto T, Matsubara Y et al (2015) Inhibition of Rat 5alpha-reductase activity and testosterone-induced sebum synthesis in hamster sebocytes by an extract of quercus acutissima cortex. Evid Based Complement Alternat Med. 2015:853846
67.
Yang N, Zhang H, Cai X, Shang Y (2018) Epigallocatechin-3-gallate inhibits inflammation and epithelialmesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma. Int J Mol Med 41(2):818–828PubMed
68.
Shi J, Deng H, Pan H, Xu Y, Zhang M (2017) Epigallocatechin-3-gallate attenuates microcystin-LR induced oxidative stress and inflammation in human umbilical vein endothelial cells. Chemosphere 168:25–31PubMed
69.
Guo M, An F, Wei X, Hong M, Lu Y (2017) Comparative effects of schisandrin A, B, and C on acne-related inflammation. Inflammation 40(6):2163–2172PubMed
70.
Batubara I, Kuspradini H, Muddathir AM, Mitsunaga T (2014) Intsia palembanica wood extracts and its isolated compounds as Propionibacterium acnes lipase inhibitor. J Wood Sci 60(2):169–174
71.
Moon JE, Shin J-H, Kwon O, Kim JY, Jomf J (2015) A standardized extract of rhus verniciflua stokes protects wistar rats against lipopolysaccharide-induced acute inflammation. J Med Food 18(11):1223–1230PubMed
72.
Kahkeshani N, Farzaei F, Fotouhi M et al (2019) Pharmacological effects of gallic acid in health and disease: a mechanistic review. Iran J Basic Med Sci 22(3):225–237PubMedPubMedCentral
73.
Lin WH, Kuo HH, Ho LH, Tseng ML, Siao AC, Hung CT et al (2015) Gardenia jasminoides extracts and gallic acid inhibit lipopolysaccharide-induced inflammation by suppression of JNK2/1 signaling pathways in BV-2 cells. Iran J Basic Med Sci 18(6):555–562PubMedPubMedCentral
74.
Wei G, Wu Y, Gao Q et al (2018) Gallic acid attenuates postoperative intra-abdominal adhesion by inhibiting inflammatory reaction in a rat model. Med Sci Monit 24:827–838PubMedPubMedCentral
75.
Oyagbemi AA, Omobowale TO, Saba AB et al (2016) Gallic acid ameliorates cyclophosphamide-induced neurotoxicity in Wistar rats through free radical scavenging activity and improvement in antioxidant defense system. J Diet Suppl 13(4):402–419PubMed
76.
Mohamed HM, Abd El-Twab SM (2016) Gallic acid attenuates chromium-induced thyroid dysfunction by modulating antioxidant status and inflammatory cytokines. Environ Toxicol Pharmacol 48:225–236PubMed
77.
Tsai PJ, Huang WC, Hsieh MC et al (2015) Flavones isolated from scutellariae radix suppress propionibacterium acnes-induced cytokine production in vitro and in vivo. Molecules 21(1):E15PubMed
78.
Lim BO, Yu BP, Kim SC, Park DK (1999) The antioxidative effect of ganhuangenin against lipid peroxidation. Phytother Res 13(6):479–483PubMed
79.
Nian H, Ma M-H, Nian S-S, Xu L-L (2009) Antiosteoporotic activity of icariin in ovariectomized rats. Phytomedicine 16(4):320–326PubMed
80.
Xu CQ, Liu BJ, Wu JF et al (2010) Icariin attenuates LPS-induced acute inflammatory responses: involvement of PI3K/Akt and NF-kappaB signaling pathway. Eur J Pharmacol 642(1–3):146–153PubMed
81.
Kong L, Liu J, Wang J, Luo Q, Zhang H, Liu B et al (2015) Icariin inhibits TNF-alpha/IFN-gamma induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes. Int Immunopharmacol 29(2):401–407PubMed
82.
Song YH, Cai H, Zhao ZM et al (2016) Icariin attenuated oxidative stress induced-cardiac apoptosis by mitochondria protection and ERK activation. Biomed Pharmacother 83:1089–1094PubMed
83.
Li WW, Gao XM, Wang XM, Guo H, Zhang BL (2011) Icariin inhibits hydrogen peroxide-induced toxicity through inhibition of phosphorylation of JNK/p38 MAPK and p53 activity. Mutat Res 708(1–2):1–10PubMed
84.
Demetzos C, Dimas KS (2001) Labdane-type diterpenes: chemistry and biological activity. Stud Nat Prod Chem 25:235–292
85.
Girón N, Través PG, Rodríguez B et al (2008) Supression of inflammatory responses by labdane-type diterpenoids. Toxicol Appl Pharmacol 228(2):179–189PubMed
86.
Van Kiem P, Anh HLT, Nhiem NX et al (2012) Labdane-type diterpenoids from the rhizomes of Hedychium coronarium inhibit lipopolysaccharide-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells. Chem Pharm Bull (Tokyo) 60(2):246–250
87.
Liu F, He Y, Liang Y et al (2013) PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in Hepatocellular carcinoma. Cancer Cell Int 13(1):108PubMedPubMedCentral
88.
Kwon HH, Yoon JY, Park SY, Min S, Kim YI, Park JY et al (2015) Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent targeting multiple pathogenic factors of acne. Invest Dermatol 135(6):1491–1500
89.
Zhu Y, Li X, Chen J, Chen T, Shi Z, Lei M et al (2016) The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease. Int Immunopharmacol 30:74–84PubMed
90.
Prasad S, Kalra N, Singh M, Shukla Y (2008) Protective effects of lupeol and mango extract against androgen induced oxidative stress in Swiss albino mice. Asian J Androl 10(2):313–318PubMed
91.
Semwal DK, Semwal RB, Combrinck S, Viljoen A (2016) Myricetin: a dietary molecule with diverse biological activities. Nutrients 8(2):90PubMedPubMedCentral
92.
Hou W, Hu S, Su Z et al (2018) Myricetin attenuates LPS-induced inflammation in RAW 264.7 macrophages and mouse models. Future Med Chem 10(19):2253–2264PubMed
93.
da Lee H, Lee CS (2016) Flavonoid myricetin inhibits TNF-alpha-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-kappaB pathways in human keratinocytes. Eur J Pharmacol 784:164–172PubMed
94.
Cho BO, Yin HH, Park SH et al (2016) Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-kappaB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages. Biosci Biotechnol Biochem 80(8):1520–1530PubMed
95.
Kang KA, Wang ZH, Zhang R et al (2010) Myricetin protects cells against oxidative stress-induced apoptosis via regulation of PI3K/Akt and MAPK signaling pathways. Int J Mol Sci 11(11):4348–4360PubMedPubMedCentral
96.
Chobot V, Hadacek F (2011) Exploration of pro-oxidant and antioxidant activities of the flavonoid myricetin. Redox Rep 16(6):242–247PubMed
97.
Pereira M, Siba I, Chioca L et al (2011) Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Prog Neuropsychopharmacol Biol Psychiatry 35(7):1636–1644PubMed
98.
Qi S, Feng Z, Li Q, Qi Z, Zhang Y (2017) Myricitrin modulates NADPH oxidase-dependent ROS production to inhibit endotoxin-mediated inflammation by blocking the JAK/STAT1 and NOX2/p47(phox) pathways. Oxid Med Cell Longev 2017:9738745PubMedPubMedCentral
99.
Gao J, Chen S, Qiu Z et al (2018) Myricitrin ameliorates ethanol-induced steatosis in mouse AML12 liver cells by activating AMPK, and reducing oxidative stress and expression of inflammatory cytokines. Mol Med Rep 17(5):7381–7387PubMed
100.
Domitrovic R, Rashed K, Cvijanovic O, Vladimir-Knezevic S, Skoda M, Visnic A (2015) Myricitrin exhibits antioxidant, anti-inflammatory and antifibrotic activity in carbon tetrachloride-intoxicated mice. Chem Biol Interact 230:21–29PubMed
101.
Sun GB, Qin M, Ye JX et al (2013) Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE−/− mice. Toxicol Appl Pharmacol 271(1):114–126PubMed
102.
Jung MK, Ha S, Son JA et al (2012) Polyphenon-60 displays a therapeutic effect on acne by suppression of TLR2 and IL-8 expression via down-regulating the ERK1/2 pathway. Arch Dermatol Res 304(8):655–663PubMed
103.
Sidahmed HM, Hashim NM, Amir J et al (2013) Pyranocycloartobiloxanthone A, a novel gastroprotective compound from Artocarpus obtusus Jarret, against ethanol-induced acute gastric ulcer in vivo. Phytomedicine 20(10):834–843PubMed
104.
Hashim NM, Rahmani M, Ee GCL et al (2012) Antioxidant, antimicrobial and tyrosinase inhibitory activities of xanthones isolated from Artocarpus obtusus FM Jarrett. Molecules 17(5):6071–6082PubMedPubMedCentral
105.
Farzaei MH, Rahimi R, Nikfar S, Abdollahi M (2018) Effect of resveratrol on cognitive and memory performance and mood: a meta-analysis of 225 patients. Pharmacol Res 128:338–344PubMed
106.
Taylor EJ, Yu Y, Champer J, Kim J (2014) Resveratrol demonstrates antimicrobial effects against propionibacterium acnes in vitro. Dermatol Ther (Heidelb) 4(2):249–257
107.
Docherty JJ, McEwen HA, Sweet TJ, Bailey E, Booth TD (2007) Resveratrol inhibition of Propionibacterium acnes. J Antimicrob Chemother 59(6):1182–1184PubMed
108.
Leejae S, Hasap L, Voravuthikunchai SP (2013) Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate. J Med Microbiol 62(Pt 3):421–428PubMed
109.
Chorachoo J, Amnuaikit T, Voravuthikunchai SP (2013) Liposomal encapsulated rhodomyrtone: a novel antiacne drug. Evid Based Complement Alternat Med 2013:157635PubMedPubMedCentral
110.
Saising J, Ongsakul M, Voravuthikunchai SP (2011) Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci. J Med Microbiol 60(12):1793–1800PubMed
111.
Park SY, Kim YH, Kim Y et al (2011) Upregulation of heme oxygenase-1 via PI3K/Akt and Nrf-2 signaling pathways mediates the anti-inflammatory activity of Schisandrin in Porphyromonas gingivalis LPS-stimulated macrophages. Immunol Lett 139:93–101PubMed
112.
Cai Z, Liu J, Bian H, Cai J, Zhu G (2016) Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Arch Pharm Res 39(4):499–507PubMed
113.
Ran J, Ma C, Xu K, et al (2018) Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-kappaB and MAPK signal pathways. Drug Des Devel Ther 12:1195–1204
114.
Takanche JS, Lee YH, Kim JS et al (2018) Anti-inflammatory and antioxidant properties of Schisandrin C promote mitochondrial biogenesis in human dental pulp cells. Int Endod J 51(4):438–447PubMed
115.
Kwon DH, Cha HJ, Choi EO, Leem SH, Kim GY, Moon SK et al (2018) Schisandrin A suppresses lipopolysaccharide-induced inflammation and oxidative stress in RAW 264.7 macrophages by suppressing the NF-kappaB, MAPKs and PI3K/Akt pathways and activating Nrf2/HO-1 signaling. Int J Mol Med 41(1):264–74
116.
Ying W, Li ZC, Li-Qing Y, Mai L, Mei T (2018) Schisandrin B alleviates acute oxidative stress via modulating Nrf2/Keap1-mediated antioxidant pathway. Appl Physiol Nutr Metab 2018:1–24.
117.
Muddathir AM, Yamauchi K, Mitsunaga T (2013) Anti-acne activity of tannin-related compounds isolated from Terminalia laxiflora. J Wood Sci 59(5):426–431
118.
Sultana N (2011) Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem 26(5):616–642PubMed
119.
Zhang Z, Zhang H, Chen R, Wang Z (2018) Oral supplementation with ursolic acid ameliorates sepsis-induced acute kidney injury in a mouse model by inhibiting oxidative stress and inflammatory responses. Mol Med Rep 17(5):7142–7148PubMedPubMedCentral
120.
Peng J, Ren X, Lan T et al (2016) Renoprotective effects of ursolic acid on ischemia/reperfusion induced acute kidney injury through oxidative stress, inflammation and the inhibition of STAT3 and NFkappaB activities. Mol Med Rep 14(4):3397–3402PubMed
121.
Ma JQ, Ding J, Zhang L, Liu CM (2014) Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-kappaB pathway. Environ Toxicol Pharmacol 37(3):975–983PubMed
122.
Fabbrocini G, Staibano S, De Rosa G et al (2011) Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol 12(2):133–141PubMed
123.
Pan-In P, Wongsomboon A, Kokpol C, Chaichanawongsaroj N, Wanichwecharungruang S (2015) Depositing alpha-mangostin nanoparticles to sebaceous gland area for acne treatment. J Pharmacol Sci 129(4):226–232PubMed
124.
Lee JW, Kang YJ, Choi HK, Yoon YG (2018) Fractionated Coptis chinensis extract and its bioactive component suppress Propionibacterium acnes-stimulated inflammation in human keratinocytes. J Microbiol Biotechnol
125.
Im M, Kim SY, Sohn KC, Choi DK, Lee Y, Seo YJ et al (2012) Epigallocatechin-3-gallate suppresses IGF-I-induced lipogenesis and cytokine expression in SZ95 sebocytes. J Invest Dermatol 132(12):2700–2708PubMed
126.
Coenye T, Brackman G, Rigole P, De Witte E, Honraet K, Rossel B et al (2012) Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds. Phytomedicine 19(5):409–412PubMed
127.
Sultan MZ, Jeon YM, Moon SS (2008) Labdane-type diterpenes active against acne from pine cones (Pinus densiflora). Planta med 74(4):449–452PubMed
128.
Sharma R, Kishore N, Hussein A, Lall N (2013) Antibacterial and anti-inflammatory effects of Syzygium jambos L. (Alston) and isolated compounds on acne vulgaris. BMC Complement Altern Med 13:292
129.
Wunnoo S, Saising J, Voravuthikunchai SP (2017) Rhodomyrtone inhibits lipase production, biofilm formation, and disorganizes established biofilm in Propionibacterium acnes. Anaerobe 43:61–68PubMed
130.
Saising J, Voravuthikunchai SP (2012) Anti-Propionibacterium acnes activity of rhodomyrtone, an effective compound from Rhodomyrtus tomentosa (Aiton) Hassk. leaves. Anaerobe 18(4):400–404PubMed
Metadaten
Titel
Promising plant-derived secondary metabolites for treatment of acne vulgaris: a mechanistic review
verfasst von
Samaneh Soleymani
Mohammad Hosein Farzaei
Arman Zargaran
Somayeh Niknam
Roja Rahimi
Publikationsdatum
26.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-019-01968-z

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise